Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Buy
104,801
+43,055
+70% +$4.39M 0.01% 1029
2025
Q4
$6.21M Buy
61,746
+54,321
+732% +$5.36M 0.01% 1318
2025
Q3
$642K Buy
+7,425
New +$587K ﹤0.01% 3030
2025
Q2
Sell
-58,855
Closed -$4.17M 4876
2025
Q1
$4.17M Buy
58,855
+28,149
+92% +$2.2M 0.01% 1542
2024
Q4
$2.4M Sell
30,706
-2,760
-8% -$258K ﹤0.01% 2254
2024
Q3
$3.42M Sell
33,466
-43,633
-57% -$3.62M 0.01% 1692
2024
Q2
$5.85M Buy
77,099
+29,571
+62% +$2.1M 0.01% 1271
2024
Q1
$3.57M Sell
47,528
-7,882
-14% -$627K 0.01% 1691
2023
Q4
$4.08M Buy
55,410
+37,689
+213% +$2.33M 0.01% 1523
2023
Q3
$815K Buy
17,721
+2,732
+18% +$121K ﹤0.01% 2464
2023
Q2
$632K Sell
14,989
-33,492
-69% -$1.27M ﹤0.01% 2476
2023
Q1
$1.26M Buy
48,481
+12,272
+34% +$363K 0.01% 1737
2022
Q4
$1.08M Buy
+36,209
New +$1.01M ﹤0.01% 1774

Other funds holding NUVL

Squarepoint's NUVL Position: Q1 2026 in Review

Squarepoint increased its Nuvalent (NUVL) stake by 70% in Q1 2026, buying an estimated $4.39M and bringing the position to 104,801 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #1029.

Squarepoint first reported a position in NUVL in Q4 2022 and has held it in 13 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Squarepoint held 104,801 shares of Nuvalent worth $10.7M as of Q1 2026.
  • Squarepoint bought 43,055 Nuvalent shares in Q1 2026, an estimated $4.39M.
  • Nuvalent made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1029 holding.
  • Squarepoint first reported a position in Nuvalent in Q4 2022 and has held it in 13 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.